Follow DNDi on FacebookFollow DNDi on TwitterFollow DNDi on LinkedInrss Donate Now to DNDi

Treatments

To date, DNDi has developed 6 new treatments for neglected patients that are available in the field:

  • ASAQ to treat malaria, launched in 2007

  • ASMQ to treat malaria, launched in 2008

  • NECT to treat late-stage sleeping sickness (human African trypanosomiasis), launched in 2009

  • SSG&PM to treat visceral leishmaniasis (kala azar) in Africa, launched in 2010

  • A set of combination therapies to treat visceral leishmaniasis (kala azar) in Asia, launched in 2011

  • Pediatric dosage form of benznidazole to treat Chagas disease in children, launched in 2011